Durable response after the discontinuation of pembrolizumab treatment due to an adverse event in a patient with advanced endometrial cancer: A case report

The persistence of antitumor effects has been reported after the completion of treatment with immune checkpoint inhibitors (ICIs) for various types of carcinoma, such as malignant melanoma, exhibiting a durable response. A durable response has also been noted after the discontinuation of treatment a...

Descripción completa

Detalles Bibliográficos
Autores principales: Umihira, Shuntaro, Koyanagi, Takahiro, Tamura, Kohei, Takahashi, Yoshifumi, Yoshiba, Takahiro, Takahashi, Suzuyo, Taneichi, Akiyo, Saga, Yasushi, Takei, Yuji, Fujiwara, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115643/
https://www.ncbi.nlm.nih.gov/pubmed/35619629
http://dx.doi.org/10.3892/etm.2022.11336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115643/
https://www.ncbi.nlm.nih.gov/pubmed/35619629
http://dx.doi.org/10.3892/etm.2022.11336

Ejemplares similares